Influence of proton pump inhibitors on gastritis diagnosis and pathologic gastric changes

Table 1 Baseline patient characteristics n (%)

Characteristics	Value
Age, median (range), yr	50 (20-87)
Gender
Male	150 (50)
Female	150 (50)
Symptoms
Abdominal burn	152 (50.70)
Heart burn	37 (12.30)
Dyspepsia	33 (11)
Past medical history
Hypertension	81 (27)
Dyslipidemia	53 (17.7)
Diabetes mellitus	36 (12)
Hypothyroidism	9 (3)
Social habits
Smoking	126 (42)
Exercise	98 (32.7)
Alcohol intake	62 (20.7)
Medication history
Anti hypertensives	86 (28.7)
Anti dyslipidemics	54 (18)
Oral hypoglycemics	28 (9.3)
Sedatives	15 (5)
Anti-depressants	16 (5.3)
PPIs1	155 (51.7)
Indications for PPI use
Gastritis	21 (13.5)
GERD	48 (31)
GI ulcer	10 (6.5)
Undocumented diagnosis	76 (49)

¹Proton pump inhibitors used: Rabeprazole (47%), esomeprazole (33%), omeprazole (17%), others (3%). GERD: Gastroesophageal reflux disease; PPIs: Proton pump inhibitors; GI: Gastrointestinal.